» Articles » PMID: 38018575

New Insights on the Potential Effect of Progesterone in Covid-19: Anti-inflammatory and Immunosuppressive Effects

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a pandemic disease caused by severe acute respiratory syndrome CoV type 2 (SARS-CoV-2). COVID-19 is higher in men than women and sex hormones have immune-modulator effects during different viral infections, including SARS-CoV-2 infection. One of the essential sex hormones is progesterone (P4).

Aims: This review aimed to reveal the association between P4 and Covid-19.

Results And Discussion: The possible role of P4 in COVID-19 could be beneficial through the modulation of inflammatory signaling pathways, induction of the release of anti-inflammatory cytokines, and inhibition release of pro-inflammatory cytokines. P4 stimulates skew of naïve T cells from inflammatory Th1 toward anti-inflammatory Th2 with activation release of anti-inflammatory cytokines, and activation of regulatory T cells (Treg) with decreased interferon-gamma production that increased during SARS-CoV-2 infection. In addition, P4 is regarded as a potent antagonist of mineralocorticoid receptor (MR), it could reduce MRs that were activated by stimulated aldosterone from high AngII during SARS-CoV-2. P4 active metabolite allopregnanolone is regarded as a neurosteroid that acts as a positive modulator of γ-aminobutyric acid (GABA ) so it may reduce neuropsychiatric manifestations and dysautonomia in COVID-19 patients.

Conclusion: Taken together, the anti-inflammatory and immunomodulatory properties of P4 may improve central and peripheral complications in COVID-19.

Citing Articles

New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effects.

Al-Kuraishy H, Al-Maiahy T, Al-Gareeb A, Alexiou A, Papadakis M, Elhussieny O Immun Inflamm Dis. 2023; 11(11):e1100.

PMID: 38018575 PMC: 10683562. DOI: 10.1002/iid3.1100.

References
1.
Beagley K, Gockel C . Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol. 2003; 38(1):13-22. DOI: 10.1016/S0928-8244(03)00202-5. View

2.
Onohuean H, Al-Kuraishy H, Al-Gareeb A, Qusti S, Alshammari E, El-Saber Batiha G . Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(10):2013-2021. PMC: 8417660. DOI: 10.1007/s00210-021-02147-6. View

3.
Alexandris N, Lagoumintzis G, Chasapis C, Leonidas D, Papadopoulos G, Tzartos S . Nicotinic cholinergic system and COVID-19: evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep. 2021; 8:73-83. PMC: 7776751. DOI: 10.1016/j.toxrep.2020.12.013. View

4.
Al-Kuraishy H, Al-Gareeb A, Waheed H, Al-Maiahy T . Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice. J Adv Pharm Technol Res. 2018; 9(3):80-86. PMC: 6174705. DOI: 10.4103/japtr.JAPTR_273_18. View

5.
Al-Kuraishy H, Al-Gareeb A, Alkazmi L, Alexiou A, El-Saber Batiha G . Levamisole Therapy in COVID-19. Viral Immunol. 2021; 34(10):722-725. DOI: 10.1089/vim.2021.0042. View